Papatheodoridi M. Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in non-cirrhotic HBeAg-negative Chronic Hepatitis B patients: Results from the DARING-B prospective Greek study. PS-159.
Onderzoekers ontdekken 3D-structuur van 2 cruciale malaria-eiwitten
okt 2025 | Parasitaire infecties